(MedPage Today) — One of the largest autism trials of leucovorin (Wellcovorin), a drug used to treat cerebral folate deficiency, was retracted on Jan. 29 by the European Journal of Pediatrics, a Springer Nature journal.
The randomized, double…
Source:
www.medpagetoday.com
Medical Disclaimer:
This content is shared for informational and educational purposes only.
It does not constitute medical, legal, or policy advice.
Healthcare decisions should always be made in consultation with qualified professionals.
